E&G Advisors, LP Bristol Myers Squibb CO Transaction History

E&G Advisors, LP

$357 Million
Q3 2024

A detailed history of E&G Advisors, LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, E&G Advisors, LP holds 5,451 shares of BMY stock, worth $287,049. This represents 0.08% of its overall portfolio holdings.

Number of Shares

5,451

Previous 5,851 6.84%

Holding current value

$287,049

Previous $242,000 16.53%

% of portfolio

0.08%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$39.66 - $51.75 $15,863 - $20,700	-400 Reduced 6.84%	5,451 $282,000
Q2 2024 Jul 18, 2024	BUY	$40.25 - $52.99 $12,075 - $15,897	300 Added 5.4%	5,851 $242,000
Q1 2024 Apr 19, 2024	BUY	$47.98 - $54.4 $14,441 - $16,374	301 Added 5.73%	5,551 $301,000
Q4 2023 Jan 25, 2024	SELL	$48.48 - $57.85 $29,087 - $34,710	-600 Reduced 10.26%	5,250 $269,000
Q3 2023 Oct 25, 2023	SELL	$57.89 - $64.73 $2,894 - $3,236	-50 Reduced 0.85%	5,850 $339,000
Q1 2023 Jul 20, 2023	SELL	$65.71 - $74.53 $46,325 - $52,543	-705 Reduced 10.67%	5,900 $408,000
Q1 2023 Apr 17, 2023	BUY	$65.71 - $74.53 $52,896 - $59,996	805 Added 13.88%	6,605 $457,000
Q4 2022 Jan 13, 2023	BUY	$68.48 - $81.09 $13,696 - $16,218	200 Added 3.57%	5,800 $0
Q3 2022 Oct 11, 2022	SELL	$0.13 - $76.84 $9 - $5,378	-70 Reduced 1.23%	5,600 $398,000
Q2 2022 Jul 06, 2022	SELL	$72.62 - $79.98 $2,178 - $2,399	-30 Reduced 0.53%	5,670 $437,000
Q1 2022 Apr 12, 2022	SELL	$61.48 - $73.72 $49,184 - $58,976	-800 Reduced 12.31%	5,700 $416,000
Q3 2021 Oct 20, 2021	BUY	$59.17 - $69.31 $384,605 - $450,515	6,500 New	6,500 $385,000
Q2 2021 Jul 12, 2021	SELL	$61.91 - $67.42 $414,797 - $451,714	-6,700 Closed	0 $448,000
Q1 2020 Apr 08, 2020	BUY	$46.4 - $67.43 $37,120 - $53,944	800 Added 13.56%	6,700 $373,000
Q4 2019 Jan 10, 2020	SELL	$49.21 - $64.19 $98,420 - $128,380	-2,000 Reduced 25.32%	5,900 $379,000
Q3 2019 Oct 10, 2019	SELL	$42.77 - $50.71 $8,554 - $10,142	-200 Reduced 2.47%	7,900 $401,000
Q2 2019 Jul 12, 2019	BUY	$44.62 - $49.34 $26,772 - $29,604	600 Added 8.0%	8,100 $367,000
Q1 2019 Apr 18, 2019	SELL	$45.12 - $53.8 $148,896 - $177,540	-3,300 Reduced 30.56%	7,500 $358,000
Q4 2018 Jan 17, 2019	BUY	$48.76 - $63.23 $53,636 - $69,553	1,100 Added 11.34%	10,800 $561,000
Q3 2018 Oct 10, 2018	BUY	$55.19 - $62.25 $104,861 - $118,275	1,900 Added 24.36%	9,700 $602,000
Q2 2018 Jul 30, 2018	BUY	$50.53 - $62.98 $35,371 - $44,086	700 Added 9.86%	7,800 $432,000
Q1 2018 Apr 18, 2018	SELL	$59.92 - $68.98 $42,902 - $49,389	-716 Reduced 9.16%	7,100 $449,000
Q4 2017 Jan 16, 2018	BUY	$59.94 - $65.35 $89,910 - $98,024	1,500 Added 23.75%	7,816 $479,000
Q3 2017 Oct 20, 2017	BUY	$55.23 - $63.74 $348,832 - $402,581	6,316	6,316 $403,000

Others Institutions Holding BMY

# of Institutions

2,438

Shares Held

1.51B

Call Options Held

29.7M

Put Options Held

32.1M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $112B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E&G Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on E&G Advisors, LP with notifications on news.

Account